Navigation Links
Erika Schwartz MD Congratulates Oprah Winfrey for Spotlighting Bioidentical Hormones
Date:1/15/2009

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

New York, NY (PRWEB) January 15, 2009 -- Today is a big day for women's health and bioidentical hormones, says Erika Schwartz MD in her latest blog at www.derika.com.

For the first time, she says, mainstream media is acknowledging that women are suffering unnecessarily and that hormone imbalance is an overwhelming handicap that needs attention and legitimate treatments. It can no longer be swept under the rug.

Dr. Erika notes it took someone like Oprah Winfrey, who is suffering from inadequately treated thyroid problems, menopausal hormone loss and its attendant weight gain to blast the hinges off the door to bioidentical hormone therapy.

Acknowledgement is always the precursor to enlightenment, she adds.

Dr. Erika says she hopes Oprah will consider bioidenticals an important ingredient in her commitment to achieving true wellness.

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

"The next step involves educating the medical community about the existence of bioidenticals, providing them with the studies about them, teaching them the difference between how bioidenticals and non-identical hormone molecules work in the human body and making sure they know that bioidenticals are FDA approved and available at your local drugstore."

Dr. Erika says doctors also need to understand the role and usefulness of compounding pharmacies and get involved with who compounds the hormones they prescribe.

Finally, Dr. Erika says, balanced and honest studies must be undertaken on a large scale and in full view that compare the efficacy and safety of bioidenticals to their non-identical counterparts. The era of creating confusion and muddying the waters of hormone therapies has reached its end.

DrErika.com is dedicated to providing an independent, honest view on healthcare topics and issues from a position of devoted patient advocacy.

Its founder, Erika Schwartz MD, is an internationally-recognized patient advocate, practicing physician, expert in conventional and integrative medicine, author of four books and a frequent guest on TV and radio. DrErika.com doesn't tailor its stories to suit sponsors - it does not accept sponsors.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1872574.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
2. Steve and Paula Mae Schwartz Honored With Publicity Club of New Englands Crystal Bell Award
3. SAND Technology Appoints Zainab Ahmed Schwartz as CFO
4. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
5. Anapol Schwartz Attorney Named to Executive Committee of American Association for Justice
6. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
7. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
8. Mission Pharmacal Congratulates Exemplary Womens Health Researchers
9. Internet2 Congratulates FCC Rural Health Care Pilot Program Grant Awardees
10. SNM congratulates NOPR and its supporting organizations on successful conclusion of project
11. Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... in Building 2. The clinic is the group’s second in New Braunfels and 22nd ... company’s second New Braunfels location brings things full circle for the group, “It’s crazy ...
(Date:3/23/2017)... ... ... 82% of adults are unaware of the dangers that infectious bacteria play in mouth disease, ... times a day that dentists recommend. The ramifications of improper oral upkeep go far beyond ... missing 164 million hours of work each year due to dental issues. That is why ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s asthma, coronary ... , Accredited status is granted to organizations that have excellent programs for the ...
(Date:3/23/2017)... Fort Collins, CO (PRWEB) , ... March 23, ... ... services firm serving the families and businesses of the greater Fort Collins area, ... charity campaign in their ongoing community involvement program. Donations to this worthy cause ...
(Date:3/23/2017)... ... ... conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... 43rd President of the United States of America: George W. Bush , ... the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017 As a result ... with the prevalence of allergic diseases, cutting edge ... currently revolutionising the ways in which pharmaceutical and ... 2017 promises to be both a high quality ... allergy interest groups, immunologists, research scholars and doctors. ...
(Date:3/23/2017)... Summary Global ... guide Primary Hyperoxaluria - Pipeline Review, H1 2017, ... Urinary System And Sex Hormones) pipeline landscape. ... recurrent kidney and bladder stones. It results from ... include blood in the urine, pain when urinating, ...
(Date:3/23/2017)... and VANCOUVER, British Columbia , ... SPHS ) (the "Company" or "Sophiris"), a clinical ... of urological diseases, today announced that data from its ... drug as a focal treatment for localized prostate cancer, ... 2017 at the 32 nd Annual European Association ...
Breaking Medicine Technology: